ABBOTT LABORATORIES (ABT) Fundamental Analysis & Valuation

NYSE:ABT • US0028241000

109.56 USD
-1.48 (-1.33%)
At close: Mar 6, 2026
108.65 USD
-0.91 (-0.83%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ABT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

ABT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. ABT has an excellent profitability rating, but there are some minor concerns on its financial health. ABT is not valued too expensively and it also shows a decent growth rate. ABT also has an excellent dividend rating. These ratings would make ABT suitable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. ABT Profitability Analysis

1.1 Basic Checks

  • ABT had positive earnings in the past year.
  • In the past year ABT had a positive cash flow from operations.
  • Each year in the past 5 years ABT has been profitable.
  • ABT had a positive operating cash flow in 4 of the past 5 years.
ABT Yearly Net Income VS EBIT VS OCF VS FCFABT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • ABT has a Return On Assets of 16.60%. This is amongst the best in the industry. ABT outperforms 96.74% of its industry peers.
  • ABT has a Return On Equity of 27.43%. This is amongst the best in the industry. ABT outperforms 97.83% of its industry peers.
  • ABT's Return On Invested Capital of 8.88% is amongst the best of the industry. ABT outperforms 86.96% of its industry peers.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 8.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABT Yearly ROA, ROE, ROICABT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABT's Profit Margin of 31.88% is amongst the best of the industry. ABT outperforms 98.91% of its industry peers.
  • ABT's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.29%, ABT belongs to the top of the industry, outperforming 89.13% of the companies in the same industry.
  • ABT's Operating Margin has improved in the last couple of years.
  • ABT's Gross Margin of 56.19% is in line compared to the rest of the industry. ABT outperforms 55.43% of its industry peers.
  • In the last couple of years the Gross Margin of ABT has remained more or less at the same level.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
ABT Yearly Profit, Operating, Gross MarginsABT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ABT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABT is destroying value.
  • There is no outstanding debt for ABT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ABT Yearly Shares OutstandingABT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABT Yearly Total Debt VS Total AssetsABT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • ABT has an Altman-Z score of 5.28. This indicates that ABT is financially healthy and has little risk of bankruptcy at the moment.
  • ABT has a Altman-Z score of 5.28. This is in the better half of the industry: ABT outperforms 79.89% of its industry peers.
  • The Debt to FCF ratio of ABT is 1.87, which is an excellent value as it means it would take ABT, only 1.87 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.87, ABT belongs to the top of the industry, outperforming 88.04% of the companies in the same industry.
  • A Debt/Equity ratio of 0.23 indicates that ABT is not too dependend on debt financing.
  • ABT has a Debt to Equity ratio (0.23) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.28
ROIC/WACC0.89
WACC10.03%
ABT Yearly LT Debt VS Equity VS FCFABT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that ABT should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.70, ABT is not doing good in the industry: 69.02% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.24 indicates that ABT should not have too much problems paying its short term obligations.
  • ABT has a Quick ratio of 1.24. This is in the lower half of the industry: ABT underperforms 66.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABT Yearly Current Assets VS Current LiabilitesABT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABT Growth Analysis

3.1 Past

  • ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • ABT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
  • ABT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
  • Measured over the past years, ABT shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • Based on estimates for the next years, ABT will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
  • ABT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABT Yearly Revenue VS EstimatesABT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABT Yearly EPS VS EstimatesABT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ABT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.27, ABT is valued on the expensive side.
  • 80.43% of the companies in the same industry are more expensive than ABT, based on the Price/Earnings ratio.
  • ABT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.29.
  • The Price/Forward Earnings ratio is 19.08, which indicates a rather expensive current valuation of ABT.
  • ABT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABT is cheaper than 82.07% of the companies in the same industry.
  • ABT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.27
Fwd PE 19.08
ABT Price Earnings VS Forward Price EarningsABT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ABT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ABT is cheaper than 76.63% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABT indicates a rather cheap valuation: ABT is cheaper than 80.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 27.54
EV/EBITDA 17.76
ABT Per share dataABT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABT does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.85
PEG (5Y)2.98
EPS Next 2Y10.76%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ABT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.17%, ABT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.20, ABT pays a better dividend. On top of this ABT pays more dividend than 96.74% of the companies listed in the same industry.
  • ABT's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • On average, the dividend of ABT grows each year by 11.40%, which is quite nice.
  • ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ABT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
ABT Yearly Dividends per shareABT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • ABT pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
  • ABT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABT Yearly Income VS Free CF VS DividendABT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABT Dividend Payout.ABT Dividend Payout, showing the Payout Ratio.ABT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABT Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

NYSE:ABT (3/6/2026, 8:04:00 PM)

After market: 108.65 -0.91 (-0.83%)

109.56

-1.48 (-1.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.33%
Inst Owner Change3.55%
Ins Owners0.45%
Ins Owner Change1.58%
Market Cap190.51B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target136.02 (24.15%)
Short Float %0.99%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-7.44%
PT rev (3m)-7.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 21.27
Fwd PE 19.08
P/S 4.35
P/FCF 27.54
P/OCF 20.89
P/B 3.74
P/tB 8.91
EV/EBITDA 17.76
EPS(TTM)5.15
EY4.7%
EPS(NY)5.74
Fwd EY5.24%
FCF(TTM)3.98
FCFY3.63%
OCF(TTM)5.24
OCFY4.79%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)1.85
PEG (5Y)2.98
Graham Number58.27
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 8.88%
ROICexc 9.99%
ROICexgc 19.14%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.28
F-Score8
WACC10.03%
ROIC/WACC0.89
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABBOTT LABORATORIES / ABT FAQ

What is the fundamental rating for ABT stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABT.


What is the valuation status of ABBOTT LABORATORIES (ABT) stock?

ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.


What is the profitability of ABT stock?

ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 21.27 and the Price/Book (PB) ratio is 3.74.


Can you provide the expected EPS growth for ABT stock?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.5% in the next year.